Özlem Dalmızrak

550 total citations
27 papers, 408 citations indexed

About

Özlem Dalmızrak is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Özlem Dalmızrak has authored 27 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Pharmacology. Recurrent topics in Özlem Dalmızrak's work include Glutathione Transferases and Polymorphisms (11 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Computational Drug Discovery Methods (4 papers). Özlem Dalmızrak is often cited by papers focused on Glutathione Transferases and Polymorphisms (11 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Computational Drug Discovery Methods (4 papers). Özlem Dalmızrak collaborates with scholars based in Cyprus, Türkiye and Italy. Özlem Dalmızrak's co-authors include Nesrin Kartal Özer, Ayşe Ercan, Turgay Dalkara, Bülent Elibol, Meltem Müftüoğlu, İ. Hamdi Öğüş, Kerem Teralı, Gamze Tuna, Arın Doğan and Renato Baserga and has published in prestigious journals such as Cancer Research, Movement Disorders and Chemico-Biological Interactions.

In The Last Decade

Özlem Dalmızrak

27 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özlem Dalmızrak Cyprus 10 230 130 69 55 49 27 408
Rebecca Graumann Chile 10 173 0.8× 138 1.1× 92 1.3× 49 0.9× 35 0.7× 10 446
Ying Piao South Korea 12 299 1.3× 107 0.8× 69 1.0× 111 2.0× 63 1.3× 20 609
Víctor J. Asensio Spain 11 228 1.0× 78 0.6× 108 1.6× 74 1.3× 52 1.1× 17 519
Mahbuba Akther South Korea 10 343 1.5× 109 0.8× 72 1.0× 67 1.2× 62 1.3× 13 546
Huifang Liu China 10 194 0.8× 85 0.7× 54 0.8× 162 2.9× 47 1.0× 33 480
Junfang Teng China 12 130 0.6× 117 0.9× 38 0.6× 35 0.6× 37 0.8× 30 335
Qinghua Liang China 11 178 0.8× 48 0.4× 59 0.9× 64 1.2× 39 0.8× 30 391
Kavita Vats India 9 208 0.9× 84 0.6× 42 0.6× 149 2.7× 25 0.5× 22 440
Ulises Ahumada-Castro Chile 12 284 1.2× 46 0.4× 75 1.1× 119 2.2× 80 1.6× 17 461
Olga Boyd Luxembourg 5 158 0.7× 54 0.4× 98 1.4× 50 0.9× 22 0.4× 5 343

Countries citing papers authored by Özlem Dalmızrak

Since Specialization
Citations

This map shows the geographic impact of Özlem Dalmızrak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Dalmızrak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Dalmızrak more than expected).

Fields of papers citing papers by Özlem Dalmızrak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Dalmızrak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Dalmızrak. The network helps show where Özlem Dalmızrak may publish in the future.

Co-authorship network of co-authors of Özlem Dalmızrak

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Dalmızrak. A scholar is included among the top collaborators of Özlem Dalmızrak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Dalmızrak. Özlem Dalmızrak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalmızrak, Özlem, et al.. (2025). Implication of the HLA-DQA1, HLA-DQB1 and CTLA-4 alleles in the susceptibility to type 1 diabetes in Jordanian population. Molecular Biology Reports. 52(1). 330–330. 1 indexed citations
2.
Dalmızrak, Özlem, et al.. (2023). Avermectin B1a Shows Potential Anti-Proliferative and Anticancer Effects in HCT-116 Cells via Enhancing the Stability of Microtubules. Current Issues in Molecular Biology. 45(8). 6272–6282. 2 indexed citations
4.
Dalmızrak, Özlem, et al.. (2022). Evaluation of the penetration of intracoronal bleaching agents into the cervical region using different intraorifice barriers. BMC Oral Health. 22(1). 266–266. 10 indexed citations
5.
Ahram, Mamoun, et al.. (2022). Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple-Negative Breast Cancer Cells via Apoptosis. Anti-Cancer Agents in Medicinal Chemistry. 22(17). 3038–3048. 2 indexed citations
6.
Dalmızrak, Özlem, et al.. (2022). Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer. Frontiers in Bioengineering and Biotechnology. 10. 956563–956563. 38 indexed citations
7.
Teralı, Kerem, et al.. (2022). Rethinking common solvents in butyrylcholinesterase activity assays. Inorganic Chemistry Communications. 143. 109796–109796. 1 indexed citations
8.
9.
Dalmızrak, Özlem, et al.. (2018). Mechanistic and structural insights into the in vitro inhibitory action of hypericin on glutathione reductase purified from baker's yeast. Journal of Biochemical and Molecular Toxicology. 32(5). e22051–e22051. 1 indexed citations
10.
11.
Teralı, Kerem, et al.. (2018). New insights into the interaction between mammalian butyrylcholinesterase and amitriptyline: a combined experimental and computational approach. Turkish Journal of Biochemistry. 44(1). 55–61. 5 indexed citations
12.
Dalmızrak, Özlem, et al.. (2016). Fluoxetine-induced toxicity results in human placental glutathione S-transferase-π(GST-π) dysfunction. Drug and Chemical Toxicology. 39(4). 439–444. 8 indexed citations
13.
Dalmızrak, Özlem, et al.. (2015). Purification of Glutathione S-Transferase pi from Erythrocytes and Evaluation of the Inhibitory Effect of Hypericin. The Protein Journal. 34(6). 434–443. 7 indexed citations
14.
Dalmızrak, Özlem, et al.. (2011). Amitriptyline may have a supportive role in cancer treatment by inhibiting glutathione S-transferase pi (GST-π) and alpha (GST-α). Journal of Enzyme Inhibition and Medicinal Chemistry. 28(1). 131–136. 16 indexed citations
15.
Dalmızrak, Özlem, et al.. (2011). The inhibition characteristics of human placental glutathione S-transferase-π by tricyclic antidepressants: amitriptyline and clomipramine. Molecular and Cellular Biochemistry. 355(1-2). 223–231. 14 indexed citations
16.
Tuna, Gamze, et al.. (2010). Inhibition characteristics of hypericin on rat small intestine glutathione-S-transferases. Chemico-Biological Interactions. 188(1). 59–65. 20 indexed citations
17.
Dalmızrak, Özlem, et al.. (2010). Purification and Characterisation of Rat Kidney Glutathione Reductase. The Protein Journal. 29(4). 250–256. 16 indexed citations
18.
19.
Dalmızrak, Özlem, Anguo Wu, Jia Chen, et al.. (2007). Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells. Cancer Research. 67(5). 2124–2130. 20 indexed citations
20.
Müftüoğlu, Meltem, Bülent Elibol, Özlem Dalmızrak, et al.. (2003). Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Movement Disorders. 19(5). 544–548. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026